Prevention of Future Deaths reports · 2022

Alfie Stone

Regulation 28 report to prevent future deaths, reference 2022-0013, written 14 Jan 2022. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report14 Jan 2022
Reference2022-0013
DeceasedAlfie Stone
CoronerJean Harkin
Coroner areaNorthamptonshire
CategoryChild Death (from 2015) · Emergency services related deaths (2019 onwards)
Organisation namedKettering General Hospital NHS Foundation Trust
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

Regulation 28: REPORT TO PREVENT FUTURE DEATHS

NOTE: This form is to be used after an inquest.

REGULATION 28 REPORT TO PREVENT DEATHS

THIS REPORT IS BEING SENT TO:

1 Chief Coroners Office
2 East Midlands Ambulance Service (Chief Executive)
3 Kettering General Hospital (Chief Executive)

1

CORONER

I am Jean HARKIN, Assistant Coroner for the coroner area of Northamptonshire

2

CORONER’S LEGAL POWERS

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009
and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013.

3

INVESTIGATION and INQUEST

On 9th December 2021 I commenced an investigation into the death of Alfie stone aged 12
years. The inquest concluded on 10th December 2021. the medical cause of death was:
1.a Hypoxic/ischaemic brain injury and multiple organ failure
1.b Epilepsy
My narrative conclusion was that Alfie died from hypoxia and multiple organ failure
following status epilepticus and inadequate oxygenation prior to hospital admission.

4

CIRCUMSTANCES OF THE DEATH

Alfie Stone had a history of epilepsy, He had not had a seizure for over three years and he
had stopped taking anti-epileptic medication in September 2019. At 21:50 hours on the
3rd of December 2019 he had a short seizure which lasted a few minutes Followed by a
second prolonged seizure at 22:10 hours. He was attended to by paramedics from East
Midlands Ambulance Service and he was admitted to Kettering General Hospital NHS Trust
emergency department at 22:50 hours.

In the emergency department he was treated for status epilepticus but continued to have
seizures and was oxygenated, sedated, intubated, and ventilated. He did not respond to
advanced paediatric life support treatment and subsequently developed multi organ failure.
By 14:30 hours on the 4th of December 2019 a CT scan showed extensive cerebral oedema
with brain stem coning and the decision was made to withdraw intensive care therapy, he
passed away at 21:50 hours on the 4th of December 2019.

5 CORONER’S CONCERNS

Evidence was heard at the inquest that paramedics were unable to deliver oxygen to Alfie
for more than 15 minutes due to their concern that continuous fitting movements made it
difficult for them to do so. In addition, the paramedics were not trained in the use of
buccal midazolam, an anti-epileptic drug that can be given into the skin between teeth and
cheek (side of mouth), onto the gums. Evidence was heard from a consultant that this
method should be used by paramedics when it is difficult to administer rectal or IV
medication due to continuous fitting movements and that this medication could be more
effective in the early stages of fitting as it is a more effective medication than diazepam.

Regulation 28 – After Inquest
Document Template Updated 30/07/2021

 The pathologist gave evidence stating that interruption of oxygen supply for more than five
minutes was sufficient to cause a global hypoxia. He also found evidence at post-mortem
examination of aspiration (“evidence of food contents in the lung”). A Paramedic confirmed
that had he known this then he would have performed suction to prevent aspiration.

BRIEF SUMMARY OF MATTERS OF CONCERN

(1) Apparent lack of training of paramedics in the use of Buccal Midazolam
(2) No other form of oxygenation attempted such as bagging or the child being taken
earlier to the ambulance to secure and deliver oxygen
(3) No suction attempted and the question was not asked of the parents as to whether the
child had vomited.
(4) No evidence of training to the paramedics who attended and gave evidence following an
independent Serious Incident Report and its agreed recommendations
(5) East Midlands Ambulance Service not accepting the recommendation 3 within the report
to carry and administer Buccal Midazolam when necessary.

6

ACTION SHOULD BE TAKEN

In my opinion action should be taken to prevent future deaths and I believe you (and/or
your organisation) have the power to take such action.

7

YOUR RESPONSE

You are under a duty to respond to this report within 56 days of the date of this report,
namely by February 24, 2022. I, the coroner, may extend the period.

Your response must contain details of action taken or proposed to be taken, setting out the
timetable for action. Otherwise, you must explain why no action is proposed.
COPIES and PUBLICATION

8

I have sent a copy of my report to the Chief Coroner and to the following Interested
Persons:
EAST MIDLANDS AMBULANCE SERVICE and the LOCAL SAFEGUARDING BOARD (The
deceased was under 18 Years of Age). I have also sent it to Kettering General Hospital who
may find it useful or of interest.

I am also under a duty to send a copy of your response to the Chief Coroner and all
interested persons who in my opinion should receive it.

I may also send a copy of your response to any person who I believe may find it useful or
of interest.

The Chief Coroner may publish either or both in a complete or redacted or summary form.
He may send a copy of this report to any person who he believes may find it useful or of
interest.

You may make representations to me, the coroner, at the time of your response about the
release or the publication of your response by the Chief Coroner.

9

Dated: 14/01/2022

Regulation 28 – After Inquest
Document Template Updated 30/07/2021

 Jean HARKIN
Assistant Coroner for
Northamptonshire

Regulation 28 – After Inquest
Document Template Updated 30/07/2021

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from East Midlands Ambulance Service (PDF)
CONFIDENTIAL 

Ms J Harkin  
HM Assistant Coroner for 
Northamptonshire 
Constabulary Block 
Angel Square 
Northampton NN1 1ED 

Dear Ms Harkin   

Trust Headquarters 
1 Horizon Place 
Mellors Way 
Nottingham Business Park 
Nottingham 
NG8 6PY 

Website: www.emas.nhs.uk 

24 February 2022 

Re: Report to Prevent Future Deaths: Alfie Stone deceased 

Thank you for your Regulation 28 Report to Prevent Future Deaths, dated 14 January 
2022, bringing to my attention HM Coroner’s concerns arising from the Inquest into 
the death of Mr Alfie Stone.  

I would like to assure you that within the East Midlands Ambulance Service (EMAS) all 
matters related to patient safety are taken extremely seriously.  Matters arising from 
Coroners’ Inquests from which lessons can be learnt, including Prevention of Future 
Death Reports, are discussed within the Incident Review Group. 

Coroner’s Concerns 

1. Apparent lack of training of paramedics in the use of buccal midazolam.

The paramedics administered rectal diazepam which was the treatment available 
within EMAS. Rectal diazepam is on the EMAS medicines formulary for the treatment 
of convulsions and is a recognised treatment within the UK ambulance service clinical 
practice guidelines, developed by the Joint Royal Colleges Ambulance Liaison 
Committee (JRCALC), who develop guidance for all ambulance services on behalf of 
the Association of Ambulance Chief Executives. This also aligns with recommendations 
from the National Institute for Health and Care Excellence (NICE). The NICE pathway 
for treating prolonged or repeated seizures in the community states:   

Administer buccal midazolam as first-line treatment in children, young people 
and adults with prolonged or repeated seizures in the community. Administer 
rectal diazepam if preferred or if buccal midazolam is not available. (Available 
from  https://pathways.nice.org.uk/pathways/epilepsy last updated 15 December 
2021). 

When buccal midazolam is available in the home as a medication prescribed by the 
patient’s General Practitioner or hospital team, then EMAS paramedics can administer 

Respond | Develop | Collaborate 

 
 
 this (where family/carer are unable to do so) according to JRCALC buccal midazolam 
guidance. This is a recent addition to EMAS JRCALC guidance which is available to 
EMAS staff to access as an ‘App’ on their phone, iPad or other electronic device. It is to 
be added to the EMAS Scope of Practice Policy to ensure clarity for paramedic staff 
that they can administer within EMAS guidance.  

Buccal midazolam comes as a pre-filled oral syringe with the dose prescribed by the 
doctor according to the child’s age. Each outer container has two or four doses and 
contains a patient information leaflet with clear instructions and illustrations as to 
how to administer a dose. Please see enclosed summary of product characteristics for 
Buccolam from medicines.org.uk (ENC).  The buccal route will be familiar to 
paramedics as we administer other medicines by this route.  

As registered healthcare professionals, paramedics are responsible for their own 
continued professional development according to standards of continuing professional 
development specified by the Health and Care Professions Council and so should 
ensure they are competent in the recognition of epileptic seizures and the treatments 
they can administer.  

In the case of Alfie Stone, neither the Emergency Operations Centre (EOC) nor the 
attending responders were informed that buccal midazolam was available within the 
home for emergency treatment and so rectal diazepam was administered according to 
local and national guidance. 

Following a review of the concerns raised in the PFD notice received on 19 January 
2022, the concerns relating specifically to midazolam will be discussed at the Medicines 
Governance Group in February 2022 to assess the impact of adding buccal midazolam 
to the EMAS medicines formulary. The impact will consider treatment effectiveness, 
timely access to midazolam on Trust ambulances as it will need to be securely stored in 
a cabinet only accessible by controlled key access and it may take longer to access in an 
emergency (due to this being a Schedule 3 controlled drug within the Misuse of Drugs 
Regulations 2001) and alternative treatments.  

The Medicines Governance Group will develop an action plan that will consider 
training for all staff who would access and administer buccal midazolam in an 
emergency, as well as staff who may need to access and administer buccal midazolam 
not supplied by EMAS but held at the patient’s home or other facility. 

Buccal Midazolam is on the agenda for the February Medicines Management Group, 
which is attended by senior Medical, Pharmacy and Quality leads. The intended 
timeline will be to start the process in April 2022, on the transition from our current 
anti-convulsant medication to Buccal Midazolam along with the legal processes we 
need to adopt to carry out this transition within the legal frameworks for this 
medication. The HM Coroner will be kept updated throughout this process. 

2.  No other form of oxygenation attempted such as bagging or the child being taken 

earlier to the ambulance to secure and deliver oxygen. 

Respond | Develop | Collaborate 

Page 2 of 4 

 
 
 
 
 
 
 
 
 
 
 In order to transport Alfie from his room down the stairs to the ambulance it would be 
technically challenging to ensure safe transfer and continual bagging of Alfie. EMAS 
accepts that it would have been beneficial to have maintained oxygenation via face 
mask during transfer to the ambulance from his bedroom. Following the outcome of 
this inquest, EMAS is keen to learn and embed lessons to ensure that all clinicians are 
reminded of the need to maintain oxygenation during the transfer of patients that are 
fitting. This will be covered in the bulletin stated below under question 3. to address 
seizure management, the HM Coroner will be provided with a copy of this bulletin 
when issued to our frontline staff.   

3.  No suction attempted, and the question was not asked of the parents as to 

whether the child had vomited. 

When the crew arrived with Alfie he was conscious, alert and conversing. Whilst they 
were present Alfie started to fit, he did not vomit in the crew’s presence and therefore 
there was no requirement to utilise the suction unit. However, as part of learning from 
events a clinical bulletin reinforcing a systematic approach to seizure management and 
aspiration will be developed to enforce best practice. The bulletin will be made 
available to the HM Coroner with an anticipated date of the 7 March 2022.  

4.  No evidence of training to the paramedics who attended and gave evidence, 

following an independent Serious Incident Report and its agreed 
recommendations. 

As in point 1 above, EMAS provides rectal diazepam (and intravenous diazepam) for 
the treatment of convulsions and both are recognised treatments within the UK 
ambulance service clinical practice guidelines, developed by JRCALC, and within NICE 
guidance. Due to the discontinuation of diazepam rectal tubes 2.5mg, EMAS made a 
recommendation at its Medicines Governance Group in November 2021 to gather data 
and build a business case regarding a move to buccal midazolam, liaising with other 
Ambulance Trusts.  

The business case will be brought to the Medicines Governance Group in April 2022. 
The aim would be to introduce buccal midazolam across EMAS within the next 6 to 12 
months following appropriate review and oversight from the Clinical Governance 
Group. When midazolam is added to the Schedule 17 exemption list of the Human 
Medicines Regulations which is expected during 2022, this will speed up the 
governance and approval process. 

In addition, the EMAS Trust Pharmacist is working with JRCALC and Specialist 
Pharmacy Service to ensure that neonates under the age of three months are included 
within the national patient group direction (PGD) and JRCALC guidance to enable 
treatment for those who do not have an epilepsy passport or treatment prescribed 
within the home who may present to emergency services with convulsive status 
epilepticus in the community.  

The updated guidance, national PGD and learning from this PFD will also be shared 
across the Ambulance Pharmacists Network, a network of pharmacists from all 

Respond | Develop | Collaborate 

Page 3 of 4 

 
 
 
 
 
 ambulance services within the UK. This will ensure learning is of benefit to patients 
across all ambulance services to avoid future harm.   

5.  East Midlands Ambulance Service not accepting the recommendation 3 within the 

report to carry and administer buccal midazolam when necessary. 

Recommendation 3 of the Kettering report states: “EMAS should audit training and 
competencies of first responders in administration of buccal midazolam in children 
experiencing prolonged seizures in line with Joint Royal Colleges Ambulance Liaison 
Committee (JRCALC) guidance”.  

At the time of the incident involving Alfie, EMAS did not have buccal midazolam 
within its medicines formulary. Therefore, at that time there was not a requirement to 
audit training and competencies of first responders in administration of buccal 
midazolam in children. Our clinical staff are trained to administer buccal medication, 
(patient’s own prescribed medication) therefore had buccal midazolam been available 
this would have been an option for the staff on scene. 

I hope that the measures set out in this letter provide you with the appropriate level 
of assurance in relation to EMAS’ commitment to continuous improvement of services.  

Please do not hesitate to contact me should you require any additional information, or 
any clarification, in connection with the above.  

Yours sincerely 

Chief Executive 

Enc:  Summary of product characteristics for Buccolam from medicines.org.uk 

Respond | Develop | Collaborate 

Page 4 of 4

Related reports

Other reports by Jean Harkin

See all →

More reports categorised “Child Death (from 2015)”

See all →

Track Kettering General Hospital NHS Foundation Trust

See every Prevention of Future Deaths report matching Kettering General Hospital NHS Foundation Trust, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.